4.5 Article

Management of Clinical T2N0 Esophageal and Gastroesophageal Junction Adenocarcinoma: What Is the Optimal Treatment?

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Cardiac & Cardiovascular Systems

Patterns of Use of Induction Therapy for T2N0 Esophageal Cancer

Kristen E. Rhodin et al.

Summary: This study examined the patterns of use of induction therapy for patients with cT2N0M0 esophageal cancer, revealing differences in patient characteristics between those receiving induction therapy and upfront surgery, without any survival benefit associated with induction therapy.

ANNALS OF THORACIC SURGERY (2021)

Article Gastroenterology & Hepatology

Staging esophageal cancer: low EUS accuracy in t2n0 patients

Germana de Nucci et al.

Summary: The study evaluated the role of EUS in T2N0 EC considering the experience of two high-volume digestive endoscopic centers, and found that the accuracy of EUS staging of T2N0 EC is low.

ENDOSCOPY INTERNATIONAL OPEN (2021)

Review Cardiac & Cardiovascular Systems

Neoadjuvant Therapy Vs Upfront Surgery for Clinical T2N0 Esophageal Cancer: A Systematic Review

Biniam Kidane et al.

ANNALS OF THORACIC SURGERY (2019)

Article Cardiac & Cardiovascular Systems

Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus

Scott M. Atay et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)

Article Cardiac & Cardiovascular Systems

What is the role of neoadjuvant chemotherapy, radiation, and adjuvant treatment in resectable esophageal cancer?

Nasser Altorki et al.

ANNALS OF CARDIOTHORACIC SURGERY (2017)

Article Cardiac & Cardiovascular Systems

Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database

Traves D. Crabtree et al.

ANNALS OF THORACIC SURGERY (2013)

Review Gastroenterology & Hepatology

Epidemiology of esophageal cancer

Yuwei Zhang

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Article Medicine, General & Internal

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

P. van Hagen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Oncology

The National Cancer Data Base: A powerful initiative to improve cancer care in the United States

Karl Y. Bilimoria et al.

ANNALS OF SURGICAL ONCOLOGY (2008)

Article Oncology

Are squamous and adenocarcinomas of the esophagus the same disease?

J. Ruediger Siewert et al.

SEMINARS IN RADIATION ONCOLOGY (2007)

Article Medicine, General & Internal

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

David Cunningham et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

JS Macdonald et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)